• $745.00
    Market Cap
  • -99.92%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
214,564
-19.26%
265,747
-51.17%
544,275
N/A
Cost of Revenue
160,239
-12.21%
182,519
-55.41%
409,302
N/A
Gross Profit
54,325
-34.73%
83,228
-38.34%
134,973
N/A
Sales and Marketing Expense
696,958
-33.09%
1.0M
+325.53%
244,774
N/A
Research and Development Expense
-301,907
-8.36%
-329,452
+19.40%
-275,926
N/A
Depreciation and Amortization Expense
20,000
-90.90%
219,833
+15,922.81%
1,372
N/A
Total Operating Expenses
9.7M
+10.56%
8.7M
+344.05%
2.0M
N/A
Operating Profit
-9.6M
+11.00%
-8.7M
+372.21%
-1.8M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-844,855
+80.58%
-467,849
-86.73%
-3.5M
N/A
Interest Income and Expense and Net
-844,855
+80.58%
-467,849
-86.73%
-3.5M
N/A
Total Nonoperating Income and Expense
-2.7M
+515.80%
-444,209
-81.88%
-2.5M
N/A
Income before Taxes
-12.3M
+35.64%
-9.1M
+112.40%
-4.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
112,338
N/A
N/A
N/A
Net Income
-12.3M
+35.64%
-9.1M
+112.40%
-4.3M
N/A
Net Income from Continuing Operations Applicable to Common
-12.3M
+35.64%
-9.1M
+112.40%
-4.3M
N/A
Basic EPS and Net Income
-12.95
+4,880.77%
-0.26
+18.18%
-0.22
N/A
Diluted EPS and Net Income
-12.95
+4,880.77%
-0.26
+18.18%
-0.22
N/A
Basic Weighted Average Shares
953,272
-96.89%
30.7M
+57.83%
19.4M
N/A
Diluted Weighted Average Shares
953,272
-96.89%
30.7M
+57.83%
19.4M
N/A
Balance Sheet
Cash and Cash Equivalents
747,714
-4.79%
785,363
+187.83%
272,856
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
747,714
-4.79%
785,363
+187.83%
272,856
N/A
Total Current Assets
1.3M
+15.57%
1.1M
+157.27%
439,916
N/A
Accumulated Depreciation
101,340
+53.59%
65,982
+1,633.18%
3,807
N/A
Property and Plant and Equipment and Net
120,914
-1.68%
122,979
+40,621.52%
302
N/A
Total Long-Term Assets
120,914
-1.68%
122,979
+40,621.52%
302
N/A
Total Assets
11.7M
-12.20%
13.4M
+2,938.32%
440,218
N/A
Income Taxes Payable
121,488
-52.51%
255,820
N/A
N/A
N/A
Total Short-Term Debt
2.8M
+1,604.45%
162,656
-89.32%
1.5M
N/A
Total Current Liabilities
7.4M
+85.17%
4.0M
-23.04%
5.2M
N/A
Total Long-Term Debt
891,133
+106.53%
431,477
+1,184.69%
33,586
N/A
Total Long-Term Liabilities
7,378
-91.90%
91,089
+191.24%
31,276
N/A
Total Liabilities
7.4M
-47.22%
14.1M
+168.67%
5.2M
N/A
Retained Earnings
-34.6M
+55.41%
-22.3M
+180.00%
-8.0M
N/A
Total Stockholders Equity
4.3M
+721.24%
-694,933
-85.51%
-4.8M
N/A
Total Shares Outstanding
1.2M
-97.53%
50.2M
+155.84%
19.6M
N/A
Cash Flow
Cash from Operating Activities
-5.9M
+1.16%
-5.9M
+399.98%
-1.2M
N/A
Capital Expenditures
33,293
-43.23%
58,647
N/A
N/A
N/A
Cash from Investing Activities
-33,293
-43.23%
-58,647
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.9M
-10.76%
6.6M
+458.77%
1.2M
N/A
Financials Ratio
Gross Margin
25.32%
-19.16%
31.32%
+26.29%
24.80%
N/A
Operating Margin
-4,478.11%
+37.47%
-3,257.41%
+867.12%
-336.81%
N/A
Return on Assets
-98.28%
-25.40%
-131.75%
-88.76%
-1,171.96%
N/A
Return on Equity
-681.55%
-305.64%
331.43%
+120.15%
150.55%
N/A
Revenue Growth
-19.26%
-62.36%
-51.17%
-554.57%
11.26%
N/A
Current Ratio
0.18
-37.59%
0.28
+234.32%
0.08
N/A
Cash Ratio
0.10
-48.57%
0.20
+274.05%
0.05
N/A
Debt-to-Equity Ratio
0.85
+199.25%
-0.85
+163.56%
-0.32
N/A
Debt-to-Assets Ratio
0.31
+602.70%
0.04
-98.74%
3.53
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow